Early-start antiplatelet therapy after operation in patients with spontaneous intracerebral hemorrhage and high risk of ischemic events (E-start): Protocol for a multi-centered, prospective, open-label, blinded endpoint randomized controlled trial

BackgroundFor severe spontaneous intracerebral hemorrhage (sSICH) patients with high risk of ischemic events, the incidence of postoperative major cardiovascular/cerebrovascular and peripheral vascular events (MACCPE) is notable. Although antiplatelet therapy is a potential way to benefit these pati...

Full description

Bibliographic Details

Published in:	Frontiers in Aging Neuroscience
Main Authors:	Kaiwen Wang, Shaohua Mo, Qingyuan Liu, Jun Pu, Xiaobin Huang, Dezhi Kang, Fixin Lin, Dewei Zou, Xinguo Sun, Jinrui Ren, Xianzeng Tong, Jiangan Li, Rustam Al-Shahi Salman, Nuochuan Wang, Shuaiwei Guo, Yang Liu, Yanan Zhang, Xiong Li, Jun Wu, Shuo Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-11-01
Subjects:	severe spontaneous intracerebral hemorrhage antiplatelet therapy postoperative management major cardiovascular/cerebrovascular and peripheral vascular events randomized controlled trial
Online Access:	https://www.frontiersin.org/articles/10.3389/fnagi.2022.1020224/full